Alternative Data for Castle Biosciences
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 13 | Sign up | Sign up | Sign up |
| Sentiment | 88 | Sign up | Sign up | Sign up |
| Webpage traffic | 23,000 | Sign up | Sign up | Sign up |
| Employee Rating | 72 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 3 | Sign up | Sign up | Sign up |
| Facebook Followers | 1,035 | Sign up | Sign up | Sign up |
| Instagram Followers | 1,337 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,007 | Sign up | Sign up | Sign up |
| X Followers | 756 | Sign up | Sign up | Sign up |
| X Mentions | 3 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 606 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 66 | Sign up | Sign up | Sign up |
| Linkedin Employees | 669 | Sign up | Sign up | Sign up |
About Castle Biosciences
Castle Biosciences, Inc., a molecular diagnostics company, provides testing solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus, uveal melanoma, and mental health conditions.
| Price | $39.66 |
| Target Price | Sign up |
| Volume | 614,300 |
| Market Cap | $1.15B |
| Year Range | $14.65 - $41.39 |
| Dividend Yield | 0% |
| PE Ratio | 31.21 |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Expert Melanoma Panel Recommends Castle Biosciences’ DecisionDx®-Melanoma as a Best-Practice Tool for Managing Patients with MelanomaDecember 8 - Yahoo |
 |
Castle Biosciences announces new data on DecisionDx-Melanoma testNovember 14 - Thefly.com |
 |
Castle Biosciences, Inc. 2025 Q3 - Results - Earnings Call PresentationNovember 12 - SeekingAlpha |
Castle Biosciences to Present at the Piper Sandler 37th Annual Healthcare ConferenceNovember 11 - GlobeNewswire |
|
SciBase and Castle Biosciences expand collaboration and license agreement and enter into loan agreement of SEK 20 millionNovember 6 - PR Newswire UK |
|
|
Castle Biosciences Inc (CSTL) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic ...November 3 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 83M | 19M | 64M | -500,000 | 5.2M | -0.020 |
| Q2 '25 | 86M | 18M | 69M | 4.5M | 3.3M | 0.150 |
| Q1 '25 | 88M | 16M | 72M | -26M | 3.5M | -0.904 |
| Q4 '24 | 86M | 16M | 70M | 9.6M | 14M | 0.320 |
| Q3 '24 | 86M | 16M | 70M | 2.3M | 12M | 0.080 |
Insider Transactions View All
| MAETZOLD DEREK J filed to sell 29,513 shares at $40.1. January 7 '26 |
| MAETZOLD DEREK J filed to sell 30,852 shares at $38.1. January 7 '26 |
| MAETZOLD DEREK J filed to sell 33,530 shares at $40.4. December 29 '25 |
| MAETZOLD DEREK J filed to sell 34,360 shares at $40. December 19 '25 |
| Oelschlager Kristen M filed to sell 12,323 shares at $39.3. December 19 '25 |
Similar companies
Read more about Castle Biosciences (CSTL) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Castle Biosciences?
The Market Cap of Castle Biosciences is $1.15B.
What is Castle Biosciences' PE Ratio?
As of today, Castle Biosciences' PE (Price to Earnings) ratio is 31.21.
What is the current stock price of Castle Biosciences?
Currently, the price of one share of Castle Biosciences stock is $39.66.
How can I analyze the CSTL stock price chart for investment decisions?
The CSTL stock price chart above provides a comprehensive visual representation of Castle Biosciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Castle Biosciences shares. Our platform offers an up-to-date CSTL stock price chart, along with technical data analysis and alternative data insights.
Does CSTL offer dividends to its shareholders?
As of our latest update, Castle Biosciences (CSTL) does not offer dividends to its shareholders. Investors interested in Castle Biosciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Castle Biosciences?
Some of the similar stocks of Castle Biosciences are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.
